BioPharmaTrend
Latest News
All Topics
  • Artificial Intelligence
  • NeuroTech
  • Premium Content
  • Knowledge Center
Interviews
Companies
  • Company Directory
  • Sponsored Case Studies
  • Create Company Profile
More
  • About Us
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Subscribe
Login/Join

All Posts


Vevo Therapeutics Open-Sources Largest Single-Cell Dataset …

Vevo Therapeutics Open-Sources Largest Single-Cell Dataset with Arc Institute

Feb. 25, 2025   by Roman Kasianov     News
Vevo Therapeutics has officially released the Tahoe-100M, described as the world’s largest single-cell dataset, in collaboration with the Arc Institute. …
Continue ›››

AI in Drug Safety: From Concept to Reality, The Industry's Path Forward

Feb. 25, 2025   by Dr. Karthik Muthusamy     Artificial Intelligence
Pharmaceutical companies are dealing with an unprecedented volume of safety data with artificial intelligence moving from theoretical applications to practical …
Continue ›››
Fuse Vectors Secures $5.2M to Develop …

Fuse Vectors Secures $5.2M to Develop Cell-Free Gene Therapy Technology

Feb. 25, 2025   by BiopharmaTrend     News
Danish biotech startup Fuse Vectors has raised $5.2 million in pre-seed funding, led by venture capital firm HCVC, to advance …
Continue ›››
100 Billion Reads Per Day: Ultima …

100 Billion Reads Per Day: Ultima Genomics Expands Sequencing Capacity

Feb. 24, 2025   by Roman Kasianov     News
Ultima Genomics has launched its UG 100 Solaris sequencing platform at the Advances in Genome Biology and Technology (AGBT) Conference …
Continue ›››
Roche Introduces New DNA Sequencing Technology

Roche Introduces New DNA Sequencing Technology

Feb. 21, 2025   by Roman Kasianov     News
Roche has unveiled its proprietary Sequencing by Expansion (SBX) technology, marking its return to the next-generation sequencing (NGS) space. SBX …
Continue ›››
AI-Driven Robotics Lab Identifies TNIK Inhibition …

AI-Driven Robotics Lab Identifies TNIK Inhibition as a Novel Way to Curb Inflammatory Aging

Feb. 21, 2025   by Roman Kasianov     News
A recent study from researchers affiliated with Insilico Medicine has identified Traf2- and Nck-interacting kinase (TNIK) inhibition as a potential …
Continue ›››
Illumina and Broad Institute Launch Spatial …

Illumina and Broad Institute Launch Spatial Transcriptomics Project Ahead of AGBT Meeting

Feb. 21, 2025   by Roman Kasianov     News
Illumina has announced a collaboration with the Broad Institute on a Spatial Flagship Project aimed at advancing spatial transcriptomics research …
Continue ›››
First In-Utero Small Molecule Treatment for …

First In-Utero Small Molecule Treatment for Spinal Muscular Atrophy Shows Promising Results

Feb. 21, 2025   by Roman Kasianov     News
At St. Jude Children’s Research Hospital in Memphis, Tennessee, a novel approach to treating spinal muscular atrophy (SMA) was tested …
Continue ›››
Variational AI Secures $5.5 Million to …

Variational AI Secures $5.5 Million to Expand Foundation Model for Small Molecule Drug Discovery

Feb. 21, 2025   by BiopharmaTrend     News
Variational AI has announced the completion of a $5.5 million Seed extension round to support the market expansion of its …
Continue ›››
Evo 2: Largest Foundation Model for …

Evo 2: Largest Foundation Model for Genomic Research Across All Domains of Life

Feb. 20, 2025   by Roman Kasianov     News
Evo 2, the largest AI foundation model for biology to date, is now publicly available via NVIDIA BioNeMo (Arc Institute's …
Continue ›››
Spore.Bio Secures €23M for Its AI-Driven …

Spore.Bio Secures €23M for Its AI-Driven Photonic Handheld Pathogen Scanner

Feb. 20, 2025   by Roman Kasianov     News
Spore.Bio, a Paris-based deeptech startup, has raised $23 million in a Series A funding round, led by Singular, just two …
Continue ›››
Amid Federal Cuts, Recursion's Altitude Lab …

Amid Federal Cuts, Recursion's Altitude Lab Launches Pre-Seed Fund

Feb. 19, 2025   by Roman Kasianov     News
The recent turmoil surrounding federal research funding—including the NIH policy to cap indirect costs at 15%—has left many early-stage biotech …
Continue ›››
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
#advertisement
ThermoFisher Scientific: Integrated genetic technologies for cell therapy development
#advertisement
Webinar: AI in Clinical Trials

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
gnews  Google News
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Premium Content
  • BioTech Scout
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Membership
  • Advertise
  • Submit Company
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.